Application YC di Parallel Bio

Summer 2021Active

Parallel Bio ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 20
Stato: Active
Lanciata: 2021

Founder

Robert DiFazioFounder
Juliana HilliardFounder

Cosa fa Parallel Bio

Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of novel disease targets and drug candidates in both cancer and autoimmune disease, while collaborating with pharmaceutical companies to evaluate therapies directly in human systems to reduce the cost and risk of clinical trials. Based in San Francisco, the company was founded in 2021 by two of the world’s leading experts in replacing animal models with human-first platforms.

Application YC di Parallel Bio, ricostruita

Domanda per Y Combinator

Parallel Bio, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Parallel Bio

Describe what your company does in 50 characters or less.

Using the immune system to cure disease

What is your company going to make? Please describe your product and what it does or will do.

We're building the first comprehensive map of human biology by tracking real clinical outcomes with biological and computational tools. Our platform bypasses animal testing by focusing directly on human systems to identify new disease targets and drug candidates, mainly in cancer and autoimmune diseases. We also collaborate with pharma to test therapies on human tissue to reduce clinical trial risks.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, and the company will be based here after YC.

Explain your decision regarding location.

San Francisco is the biotech and AI hub we need to build our human-first drug discovery platform and collaborate with pharmaceutical partners.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Parallel Bio?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Parallel Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Parallel Bio si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Parallel Bio?

Parallel Bio apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato Parallel Bio?

Parallel Bio è stato fondato da Robert DiFazio, Juliana Hilliard.

Cosa fa Parallel Bio?

Using the immune system to cure disease

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Parallel Bio, e di ogni altro batch YC, è in YC Insights.